The FAB/MIC/WHO proposals for the classification of the chronic lymphoid leukemias

Reviews in Clinical and Experimental Hematology

Volumn 6, Issue 4, 2002, Pages 330-334

  Bennett, John M ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER IMMUNOLOGY; CHRONIC LYMPHATIC LEUKEMIA; CYTOGENETICS; FRANCE; HUMAN; REVIEW; T CELL LEUKEMIA; UNITED KINGDOM; UNITED STATES;

EID: 0037764937     PISSN: 11270020     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-0734.2002.00301.x     Document Type: Review

References (10)

1. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol, 42: 567-584, 1989.
2. Bennett JM, Juliusson G, Mecucci C. Meeting Report. Morphologic, immunologic, and cytogenetic classification of the chronic (mature) B and T lymphoid leukemias: Fourth Meeting of the MIC Cooperative Study Group. Cancer Res, 50: 2212, 1990.
3. Bennett JM, Berger R, Catovsky D, et al. Morphologic, immunologic and cytogenetic (MIC) working classification of acute lymphoblastic leukemias. Cancer Genet Cytogenet, 23: 189-197, 1986.
4. Bennett JM, Berger R, Catovsky D, et al. Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukemias. Second MIC Cooperative Study Group. Br J Haematol, 68: 487-494, 1988.
5. Bennett JM, Berger R, Brunning RD, et al. Recommendations for morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders. Cancer Genet Cytogenet, 32: 1-10, 1988.
6. Pawson R, Matutes E, Brito-Babapulle V, et al. Sezary cell leukaemia. a distinct T cell disorder or a variant form of T prolymphocytic leukaemia? Leukemia, 11: 1009-1013, 1997.
7. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84: 1361-1392, 1994.
8. Jaffe ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tomours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2001.
9. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94: 1840-1847, 1999.
10. Chan JK, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood, 89: 4501-4513, 1997.